SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $1,432,000 | +113.4% | 127,873 | +86.7% | 0.22% | +93.7% |
Q1 2017 | $671,000 | +4.2% | 68,473 | +14.8% | 0.11% | +15.6% |
Q4 2016 | $644,000 | +332.2% | 59,663 | +309.1% | 0.10% | +357.1% |
Q3 2016 | $149,000 | -22.4% | 14,585 | -16.5% | 0.02% | -32.3% |
Q1 2016 | $192,000 | – | 17,463 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sensato Investors LLC | 1,564,682 | $10,859,000 | 2.03% |
Matarin Capital Management, LLC | 274,291 | $1,903,580,000 | 0.39% |
AMERICAFIRST CAPITAL MANAGEMENT, LLC | 87,524 | $607,417,000 | 0.36% |
TFS CAPITAL LLC | 323,415 | $2,245,000 | 0.22% |
Nantahala Capital Management | 170,218 | $1,181,000 | 0.16% |
Ativo Capital Management LLC | 74,338 | $592,000 | 0.16% |
MENTA CAPITAL LLC | 111,985 | $777,000 | 0.12% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 229,891 | $1,595,000 | 0.11% |
GSA CAPITAL PARTNERS LLP | 270,888 | $1,880,000 | 0.09% |
BOOTHBAY FUND MANAGEMENT, LLC | 25,644 | $178,000 | 0.08% |